Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
HeartBeam, Inc. BEAT
$2.10
-$0.06 (-2.78%)
На 18:04, 12 мая 2023
+376.19%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
18510908.00000000
-
week52high
6.74
-
week52low
1.12
-
Revenue
0
-
P/E TTM
-1
-
Beta
0.00000000
-
EPS
-1.46000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 мая 2023 г. в 20:00
Описание компании
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Benchmark | Speculative Buy | 20 дек 2021 г. | |
| Truist Securities | Hold | Buy | 30 дек 2020 г. |
| Needham | Hold | Buy | 18 дек 2020 г. |
| Needham | Buy | 11 сент 2020 г. | |
| Baird | Neutral | 02 сент 2020 г. | |
| Alliance Global Partners | Buy | 02 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Brounstein Richard | D | 0 | 760 | 02 дек 2022 г. |
| Brounstein Richard | A | 111924 | 760 | 02 дек 2022 г. |
| Brounstein Richard | D | 760 | 759 | 02 ноя 2022 г. |
| Brounstein Richard | A | 111164 | 759 | 02 ноя 2022 г. |
| Brounstein Richard | D | 1519 | 760 | 02 окт 2022 г. |
| Brounstein Richard | A | 110405 | 760 | 02 окт 2022 г. |
| Persen Kenneth Harry | A | 80000 | 80000 | 16 сент 2022 г. |
| Brounstein Richard | D | 2279 | 757 | 02 сент 2022 г. |
| Brounstein Richard | A | 109645 | 757 | 02 сент 2022 г. |
| Brounstein Richard | D | 3036 | 757 | 01 авг 2022 г. |
Новостная лента
Cash Out Or Hold On To HeartBeam?
Seeking Alpha
16 дек 2022 г. в 14:40
I can only give HeartBeam a hold rating. This cardiac technology firm's stock has risen too much recently. BEAT's 3-month price performance is +349.22%. I think investors should take profit now because its product still has no FDA approval. Zero revenue until now.
HeartBeam, Inc. (BEAT) Q3 2022 Earnings Call Transcript
Seeking Alpha
12 ноя 2022 г. в 07:25
HeartBeam, Inc. (NASDAQ:BEAT ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Branislav Vajdic – Founder and Chief Executive Officer Jon Hunt – Chief Business Officer Rick Brounstein – Chief Financial Officer Conference Call Participants Jason Kolbert – Dawson James Bill Sutherland – The Benchmark Company Operator Greetings, and welcome to the HeartBeam Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
HeartBeam to Host Third Quarter 2022 Results Conference Call on Thursday November 10, 2022 at 4:30 p.m. Eastern Time
Business Wire
25 окт 2022 г. в 08:31
SANTA CLARA, Calif.
These Were the Five Best and Worst Performing Healthcare Stocks in Q3 2022
24/7 Wall Street
24 окт 2022 г. в 21:21
The healthcare industry is now starting to shift its focus away from the coronavirus pandemic to work on its core activities.
These Were The Five Best And Worst Performing Healthcare Stocks In September 2022
24/7 Wall Street
17 окт 2022 г. в 19:41
September was another lackluster month for the stock market, with the S&P 500 dropping by over 9%.